Christopher H. Cabell

机构：Pfizer (United States), Arena Pharmaceuticals (United States)

发表论文 127 篇 · 总被引 17443 次 · h-index 54

代表论文

Prevention of Infective Endocarditis (2007 · Circulation · 被引 2822)
Prevention of infective endocarditis: Guidelines from the American Heart Association (2008 · The Journal of the American Dental Association · 被引 485)
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS) (2007 · American Heart Journal · 被引 378)
Prevention of infective endocarditis: Guidelines from the American Heart Association (2007 · The Journal of the American Dental Association · 被引 354)
Analysis of the Impact of Early Surgery on In-Hospital Mortality of Native Valve Endocarditis (2010 · Circulation · 被引 311)
Non-HACEK Gram-Negative Bacillus Endocarditis (2007 · Annals of Internal Medicine · 被引 307)